Market Overview
Global
Occlusion Devices Market is projected to reach
USD 4.0 billion by the end of 2024 and grow exponentially to an anticipated value of
USD 6.5 billion in 2033 at a
CAGR of 5.5%.
Occlusion devices are medical tools designed to block off blood vessels or body passages through minimally invasive procedures. Occlusion devices may help treat conditions like aneurysms, congenital heart defects, and varicose veins by impeding abnormal blood flow or closing off unwanted pathways. These may include embolization coils, plugs, and balloons for embolization purposes while in cardiology occlusion devices provide an alternative to open surgery by closing atrial and ventricular septal defects that prevent abnormal blood circulation between chambers in the heart thereby providing improved outcomes and reduced recovery times and risks.
They play an essential role in managing vascular abnormalities and supporting healing and normal function. Their market is experiencing explosive growth as more individuals suffer cardiovascular diseases, congenital heart defects, and neurovascular conditions. major players are creating innovative products such as embolization coils, vascular plugs and septal occludes which enhance patient outcomes while decreasing recovery times.
The US Occlusion Devices Market
The US Occlusion Devices market is expected to reach USD 1.2 billion by the end of 2024 and is projected to grow significantly to an estimated USD 1.8 billion by 2033, with a CAGR of 5.2%.
The US occlusion devices market is driven by several key factors, including the increasing cases of cardiovascular diseases, neurovascular disorders, & peripheral vascular diseases. An aging population, along with rising rates of obesity & unhealthy lifestyles, is further contributing to the growth of the market.
Increasing focus on personalized medicine, where occlusion devices and treatments are tailored to individual patient needs presenting a trend towards the US occlusion devices market. There is a growing emphasis on developing innovative, minimally invasive occlusion devices that reduce patient trauma and recovery time.
Key Takeaways
- Market Growth: It is projected that the global occlusion devices market will experience growth of USD 2.3 billion at a CAGR of 5.5 % from 2025 to 2033.
- Market Definition: Occlusion devices are medical instruments used to block or restrict blood flow in specific areas of the body to treat conditions such as cardiovascular, neurovascular, or peripheral vascular diseases.
- Product Analysis: Occlusion Removal Devices is expected to dominate the market, securing the largest share in 2024.
- Application Analysis: Neurology is expected to lead the market with a revenue share of 27.1 % in 2024.
- End User Analysis: Hospital diagnostic and surgical centers are expected to dominate the generative AI in data labeling solution and services market with a market share of 36.0% in 2024.
- Regional Analysis: North America is predicted to lead the Occlusion Devices Market globally with a 34.5% market share by 2024.
Use Cases
- Stroke Prevention: In cases of atrial fibrillation, patients are at a higher risk of stroke due to blood clots forming in the heart. Left atrial appendage (LAA) occlusion devices are used to block the LAA to prevent these clots from entering the bloodstream.
- Congenital Heart Defect Closure: Occlusion devices, such as septal occludes, are utilized to close congenital heart defects like atrial septal defects (ASD) and patent ductus arteriosus (PDA). These devices allow for a minimally invasive solution to congenital defects, reducing the need for open-heart surgery & improving patient outcomes.
- Treatment of Aneurysms: Occlusion devices, such as coils & flow diverters, are often used in the treatment of cerebral and peripheral aneurysms. These devices are inserted into the aneurysm to block blood flow and prevent rupture.
- Embolization Therapy: Occlusion devices are frequently used in embolization therapy to stop blood flow to specific areas, such as tumors or abnormal blood vessels, in cases of arteriovenous malformations (AVMs) or uterine fibroids.
Market Dynamic
Drivers
Need for Effective Treatment Solutions
The increasing cases of cardiovascular diseases, neurovascular disorders, and peripheral vascular diseases are major factors driving the occlusion devices market. These conditions require effective treatment solutions, like occlusion devices, to restore proper blood flow and avert complications. The rising global prevalence of these diseases, combined with an aging population and increasing rates of unhealthy lifestyles, leads to the demand for occlusion devices.
Technological Advancements
Technological progress in minimally invasive procedures has revolutionized the occlusion device market and created an unprecedented opportunity. Non-surgical or minimally invasive treatment alternatives for occlusions offer non-traumatic recovery periods and improved patient outcomes while innovative devices with better safety and effectiveness such as embolization devices are driving its expansion.
Restraints
High Cost of Occlusion Devices
Occlusion devices, including those used for treating cardiovascular diseases or in minimally invasive procedures, can be expensive which may limit their usage, especially in regions where patients struggle to afford costly treatments or where healthcare budgets are constrained. This financial burden can restrict access to these advanced devices and impact their overall market penetration.
Stringent Regulatory Approval Processes
The development and commercialization of occlusion devices are subject to stringent regulatory approval processes. Challenges or delays in obtaining these approvals can impede market expansion, as they can slow down the introduction of new devices or technologies. Such regulatory hurdles may affect the timely availability of innovative occlusion solutions.
Opportunities
Increased Investment in Research and Development
A rising trend in the occlusion devices market is the increased investment in research and development. Companies are focusing on developing innovative solutions and improving existing technologies to stay competitive and meet the evolving needs of the healthcare sector.
Focus on Personalized Medicine
There is a growing trend towards personalized medicine, where occlusion devices are tailored to individual patient needs. Customized devices and treatment plans are becoming more prevalent, allowing for more effective and targeted interventions. Advances in materials science, device customization, and patient-specific data analysis are making it possible to create occlusion devices that are precisely suited to each patient's unique anatomical and pathological conditions.
Trends
Growing Demand for Bioresorbable Occlusion Devices
Bioresorbable occlusion devices are engineered to gradually dissolve and be absorbed by the body, eliminating the need for subsequent device removal procedures. The increasing demand for these devices is driven by their potential benefits, such as a lower risk of long-term complications and enhanced patient comfort. Manufacturers are actively investing in research and development to refine the bioresorbable materials used in these devices, aiming to enhance their safety and efficacy. This trend reflects the broader shift towards patient-centric healthcare and personalized treatment options in the field of occlusion device interventions.
Integration of Digital Technology
The integration of digital technologies with occlusion devices represents a significant trend in the market. Advanced imaging systems, such as MRI and CT scans, are increasingly being combined with occlusion devices to improve procedural accuracy. These advancements enhance the precision and effectiveness of procedures, leading to better patient outcomes and driving market growth.
Research Scope and Analysis
By Product
Occlusion removal devices is anticipated to continue to dominate the occlusion device market in 2024 based on the increasing popularity of minimally invasive procedures as well as growing awareness of devices for Cardiovascular & Neurovascular diseases. These devices are known to be effective in managing vessel obstruction, and especially in stroke patients they have proven effectivity in clearing occlusions that are required for the betterment of the patients. For instance, stent retrievers and as well as balloon occlusion devices are used more often in neurovascular interventions owing the fact that they enable and facilitate comparable clot retrieval and revascularization in the least time possible.
This makes these devices have better recovery time, shorter hospitalization periods, and generally fewer risks as compared to other conventional surgeries. These types are preferred by surgeons and health care practitioners because they are easy to handle and compatible with enhanced imaging systems that enhance the degree of accuracy in operations. On the other hand, embolization devices are mainly applied to occlude the abnormal or undesired blood vessels which supply tumors or aneurysms.
This method assists in the process of constricting the blood vessels to the target area thereby causing it to shrink or to even collapse; it is very useful in the treatment of conditions such as AVMs, aneurysms, and cancer among others. These consist of microcatheters and guidewires that enhance the delivery of such devices used in minimally invasive therapy including occlusion removal and embolization.
By Application
Neurology is expected to dominate the global occlusion devices market with a 27.1% market revenue share by 2024 due to increased neurosurgical procedures performed in developed nations as well as increased research into interventional neurology. Furthermore, enhanced research capabilities of major product manufacturers and favorable reimbursement policies for neurovascular surgeries in developed nations also play a part in this growth.
These devices can help treat neurovascular conditions like Strokes, which occur when blood flow to the brain becomes restricted and are among the leading causes of both death and long-term disability globally. The rising incidence of neurovascular disorders leads to the increasing demand for occlusion devices like stent retrievers & coil retrievers, which are critical in performing mechanical thrombectomy to remove clots and restore blood flow in the brain.
Advancements in neuro-interventional procedures have made minimally invasive techniques more viable and effective for treating conditions like aneurysms, arteriovenous malformations, and other cerebrovascular diseases. As demand for occlusion devices in neurology grows so does awareness about early treatment for such emergencies increases occlusion devices which continue to gain in popularity within neurology practices.
By End User
Hospital diagnostic and surgical centers are expected to lead with the largest revenue share of 36.0% in 2024, due to their central role in providing complex and critical care, especially for life-threatening conditions like stroke, cardiovascular diseases, and other vascular disorders. These facilities are equipped with advanced technology, including imaging and interventional tools, which are essential for accurately diagnosing and treating occlusions. Stent retrievers and balloon occlusion devices are often used in urgent situations that require immediate and highly specialized intervention, which is available in hospitals and surgical centers.
Also, the growing number of patients undergoing diagnostic and surgical procedures to manage vascular and neurological conditions is contributing to the demand for these devices in these settings. Hospitals and surgical centers offer a wide range of minimally invasive procedures that require occlusion devices, including neurovascular and cardiovascular interventions. These procedures, often performed in operating rooms and catheterization labs, require the expertise of multidisciplinary teams, which are typically housed in such institutions. The demand of occlusion devices remains strong due to adoption of advanced medical technology and expand their capacity to handle a higher volume of patients
Global Occlusion Devices Market Report is segmented based on the following
By Product
- Occlusion Removal Devices
- Balloon Occlusion Devices
- Stent Retrievers
- Coil Retrievers
- Suction & Aspiration Devices
- Embolization Devices
- Embolic Coils
- Liquid Embolic Agents
- Tubal Occlusion Devices
- Support Devices
- Microcatheters
- Guidewires
By Application
- Neurology
- Cardiology
- Peripheral Vascular Diseases
- Urology
- Oncology
- Gynecology
By End User
- Hospitals, Diagnostic Centers, & Surgical Centers
- Ambulatory Care Centers
- Research Laboratories & Academic Institutes
- Others
Regional Analysis
North America is expected to dominate the occlusion devices market in terms of revenue over the forecast period, owing to a revenue share of 34.5% in 2024, driven by an increase in reimbursement policies that are increasingly supporting MI surgeries, especially in developed countries. Such policies relieve the payment that is incurred by patients and promote the use of advanced technologies as a means of increasing the market for occlusion devices. The rising cases of chronic ailments such as cardiovascular and neurovascular diseases have led to the higher adoption of these devices in this region.
The factors that have influenced the growth of this market include enhanced technology in this region especially in occlusion removal and embolization devices since they provide better treatment solutions. Furthermore, an increased level of healthcare expenditure in the region has provided hospitals and medical centers the ability to incorporate improved occlusion devices in their operations, thereby furthering the growth of the market.
Europe which comes immediately after North America is also poised to record a huge increase during the forecast period. This region has received lots of attention due to the high rate of fatal accidents and incidences of sports injuries which in essence has resulted in to increase in medical procedures that require occlusion devices in the region thus making the region a favorable growth area.
By Region
North America
Europe
- Germany
- The U.K.
- France
- Italy
- Russia
- Spain
- Benelux
- Nordic
- Rest of Europe
Asia-Pacific
- China
- Japan
- South Korea
- India
- ANZ
- ASEAN
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of Latin America
Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Egypt
- Rest of MEA
Competitive Landscape
The occlusion devices market features several prominent players working to maintain and enhance their market positions. These companies engage in various strategies such as developing new products, forming strategic partnerships, pursuing mergers and acquisitions, and expanding into new regions to strengthen their market presence. They offer a broad range of occlusion devices and invest heavily in research and development to bring innovative and advanced solutions to the market.
Obtaining regulatory approvals is also a key focus to meet quality and safety standards. Some key players in this market include Medtronic plc, Johnson & Johnson, and Stryker Corporation. Major players operating in the market are adopting strategies such as innovating their products and services and engaging in mergers and acquisitions to expand the functionality of their product portfolios and maintain competitiveness.
Some of the prominent players in the global occlusion devices market are:
- Medtronic plc
- Boston Scientific Corporation
- Abbott Laboratories
- Terumo Corporation
- Johnson & Johnson
- Stryker Corporation
- Cook Medical Inc.
- Cardinal Health, Inc.
- Penumbra, Inc.
- MicroPort Scientific Corporation
- Penumbra, Inc.
- Others
Recent Development
- In June 2024, Front Line Medical Technologies Inc. announced that its Control of Bleeding, Resuscitation, and Arterial Occlusion System received CE Mark approval under the new European Medical Device Regulations. This device is designed for use in resuscitative endovascular balloon occlusion of the aorta (REBOA) procedures.
- In January 2024, Occlutech Holding AG received FDA approval for its Occlutech ASD occluder and Pistol Pusher, which are used to treat atrial septal defects. The company immediately began commercialization in the U.S. through an exclusive partnership with B. Braun Interventional Systems Inc.
- On June 5, 2023, Conformal Medical Inc., developer of a left atrial appendage occlusion system, successfully closed a Series D funding round, raising $35 million. The round was led by SPRIG Equity, with all major Series C investors also participating.
- In November 2023, PMcardio launched Queen of Hearts, an AI-powered medical device that marks a significant breakthrough in detecting and treating acute obstructive heart attacks, known as Acute Occlusion Myocardial Infarction (OMI). With 50 million patients globally visiting emergency departments for chest pain annually, the current standard of care often misdiagnoses and delays treatment in 50% of OMI cases, which require urgent intervention.
Report Details
| Report Characteristics |
| Market Size (2024) |
USD 4.0 Bn |
| Forecast Value (2033) |
USD 6.5 Bn |
| CAGR (2024-2033) |
5.5% |
| Historical Data |
2018 – 2023 |
| The US Market Size (2024) |
USD 1.2 Bn |
| Forecast Data |
2025 – 2033 |
| Base Year |
2023 |
| Estimate Year |
2024 |
| Report Coverage |
Market Revenue Estimation, Market Dynamics, Competitive Landscape, Growth Factors and etc. |
| Segments Covered |
By Product (Occlusion Removal Devices, Embolization Devices, and Support Devices), By Application (Neurology, Cardiology, Peripheral Vascular Diseases, Urology, Oncology, and Gynecology), By End User (Hospitals, Diagnostic Centers, & Surgical Centers, Ambulatory Care Centers, Research Laboratories & Academic Institutes, and Others) |
| Regional Coverage |
North America – The US and Canada; Europe – Germany, The UK, France, Russia, Spain, Italy, Benelux, Nordic, & Rest of Europe; Asia- Pacific– China, Japan, South Korea, India, ANZ, ASEAN, Rest of APAC; Latin America – Brazil, Mexico, Argentina, Colombia, Rest of Latin America; Middle East & Africa – Saudi Arabia, UAE, South Africa, Turkey, Egypt, Israel, & Rest of MEA
|
| Prominent Players |
Medtronic plc., Boston Scientific Corporation, Abbott Laboratories, Terumo Corporation, Johnson & Johnson, Stryker Corporation, Cook Medical Inc., Cardinal Health, Inc., Penumbra, Inc. , MicroPort Scientific Corporation, Penumbra, Inc., and Other Key Players |
| Purchase Options |
We have three licenses to opt for: Single User License (Limited to 1 user), Multi-User License (Up to 5 Users) and Corporate Use License (Unlimited User) along with free report customization equivalent to 0 analyst working days, 3 analysts working days and 5 analysts working days respectively. |
Frequently Asked Questions
The Global Occlusion Devices Market size is estimated to have a value of USD 4.0 billion in 2024 and is expected to reach USD 6.5 billion by the end of 2033.
North America is expected to be the largest market share for the Global Occlusion Devices Market with a share of about 34.5% in 2024.
Some of the major key players in the Global Occlusion Devices Market are Medtronic plc, Johnson & Johnson, and Stryker Corporation, and many others.
The market is growing at a CAGR of 5.5 percent over the forecasted period.
The Global US Market size is estimated to have a value of USD 1.2 billion in 2024 and is expected to reach USD 1.8 billion by the end of 2033.